Active Pharmaceutical Ingredient (API)

Tafamidis Meglumine (Cardiac)

TTR Stabilizer

Used for the treatment of transthyretin-mediated amyloidosis in adults with cardiomyopathy (ATTR-CM).
Technical Profile
Reference Code
Crd948
CAS Number
952766-18-8
Molecular Weight
503.30 g/mol
Chemical Class
N/A
Molecular Formula
C14H7Cl2NO3 · C7H17NO5
Therapeutic Class
N/A

Verified Brands

Medicines containing Tafamidis Meglumine (Cardiac) as an active ingredient.

Brand Name Manufacturer Formulation MRP
No verified brands found for this salt.